Celanese (NYSE:CE) Price Target Raised to $75.00 at Wells Fargo & Company

Celanese (NYSE:CEGet Free Report) had its price target hoisted by analysts at Wells Fargo & Company from $70.00 to $75.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the basic materials company’s stock. Wells Fargo & Company‘s price objective points to a potential upside of 19.02% from the stock’s current price.

Other equities analysts also recently issued reports about the stock. Evercore set a $63.00 target price on shares of Celanese in a research note on Wednesday, February 18th. Mizuho raised their price target on Celanese from $55.00 to $58.00 and gave the company a “neutral” rating in a research note on Tuesday, March 31st. Robert W. Baird raised their price target on Celanese from $65.00 to $75.00 and gave the company an “outperform” rating in a research note on Friday, March 27th. Vertical Research upgraded Celanese from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a research note on Monday, March 9th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Celanese in a research note on Wednesday, January 21st. Nine research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Celanese currently has an average rating of “Hold” and an average target price of $62.82.

Get Our Latest Report on CE

Celanese Trading Up 1.1%

CE stock traded up $0.71 during mid-day trading on Friday, reaching $63.02. The company had a trading volume of 412,370 shares, compared to its average volume of 2,543,660. The company has a debt-to-equity ratio of 2.55, a current ratio of 1.55 and a quick ratio of 0.94. The company has a market capitalization of $6.90 billion, a PE ratio of -5.92, a price-to-earnings-growth ratio of 0.46 and a beta of 0.85. The firm has a 50 day moving average of $56.44 and a 200 day moving average of $46.98. Celanese has a 12 month low of $35.13 and a 12 month high of $67.82.

Celanese (NYSE:CEGet Free Report) last issued its earnings results on Tuesday, February 17th. The basic materials company reported $0.67 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.22). The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.25 billion. Celanese had a positive return on equity of 8.75% and a negative net margin of 12.15%.Celanese’s revenue was down 6.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.45 earnings per share. Celanese has set its Q1 2026 guidance at 0.700-0.850 EPS. On average, equities analysts predict that Celanese will post 8.79 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Celanese

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. increased its position in shares of Celanese by 111.1% during the second quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock worth $28,000 after purchasing an additional 270 shares in the last quarter. National Bank of Canada FI acquired a new position in shares of Celanese during the third quarter worth $34,000. Versant Capital Management Inc increased its position in shares of Celanese by 140.4% during the third quarter. Versant Capital Management Inc now owns 827 shares of the basic materials company’s stock worth $35,000 after purchasing an additional 483 shares in the last quarter. Salomon & Ludwin LLC acquired a new position in shares of Celanese during the third quarter worth $36,000. Finally, Hartford Financial Management Inc. increased its position in shares of Celanese by 350.5% during the fourth quarter. Hartford Financial Management Inc. now owns 901 shares of the basic materials company’s stock worth $38,000 after purchasing an additional 701 shares in the last quarter. Hedge funds and other institutional investors own 98.87% of the company’s stock.

About Celanese

(Get Free Report)

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.

Recommended Stories

Analyst Recommendations for Celanese (NYSE:CE)

Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.